Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home›Services›Research services›Network meta-analysis

Network Meta-Analysis and HTA Evidence Synthesis

Network Meta-Analysis and Indirect Treatment Comparison Services

Pubrica provides network meta-analysis (NMA) and indirect treatment comparison services for HTA and market access teams, pharmaceutical companies, guideline groups and academic researchers. These methods compare treatments that have not been tested head to head, such as a new medicine and the alternatives clinicians prescribe. Pubrica’s biostatisticians and evidence synthesis specialists assess feasibility before the network is built, examine transitivity against the data and report inconsistency in full, and deliver the analysis, the report and reproducible code.

  • Feasibility assessed before the network is built, so that disconnected networks and incomparable populations are identified before any analysis
  • Transitivity examined, not asserted against the effect modifiers in the study data, since every indirect comparison depends on it
  • Inconsistency tested where a loop exists, by node-splitting or an equivalent method, and reported in full
  • MAIC and STC where the comparison is unanchored, to NICE DSU TSD 18, with the underlying assumptions stated explicitly
  • Rankings reported with their caveats, because SUCRA values and rankograms are often over-interpreted and a rank is not an effect size
What a Network Meta-Analysis Project Covers What is included and what is excluded

Feasibility and network geometryIncluded

Transitivity examined against the dataIncluded

Inconsistency tested where loops existIncluded

Reproducible code handed overIncluded

Analysing a network that does not connectNot performed; reasons reported

Evidence → feasibility → network → tested → comparison

Included in every comparison
  • Feasibility reported before analysis
  • Transitivity examined against study data
  • Inconsistency tested, not assumed
  • Code and data handed over
  • Rankings reported with caveats
Quoted per networkOn trial count and outcome complexity
R, or WinBUGS where requirednetmeta, gemtc, multinma
NICE DSU methodsTSD 2, 3, 4 and 18
ISO 9001:2015Quality management certified · cert. H3CR9TCU20251212INDQM10N

Service Scope

Our Network Meta-Analysis Services

Pubrica offers four network meta-analysis service areas that can be commissioned individually, because projects reach us at different stages, some as a research question and others with data already extracted.

Network build and feasibilityBefore any pooling, the network is drawn and tested to establish which treatments connect, through which common comparators, and whether the geometry supports the comparison you need. Where it does not, we tell you at this stage.
Transitivity and consistency assessmentThe assumption that makes an indirect comparison meaningful is transitivity — that the trials are similar enough in the factors that modify the effect. It is assessed against the effect modifiers, not asserted, and consistency between direct and indirect evidence is tested wherever the network has closed loops.
Frequentist or Bayesian estimationFitted in R with netmeta or multinma, or in a Bayesian framework where ranking probabilities and the uncertainty around them matter. The model, the priors where they apply and the convergence checks are stated rather than left in the code.
Reporting to PRISMA-NMANetwork geometry plotted, league table produced and SUCRA or P-scores reported with appropriate caveats, all reported under PRISMA-NMA with the analysis files handed over.

Who We Serve

Researchers and Organisations We Support with Network Meta-Analysis

We support academic, clinical, HTA and industry teams, most of whom use the results to inform a treatment, reimbursement or guideline decision.

Guideline development groupsComparisons of several treatment options for guideline committees, where head-to-head trials have not been run.
HTA and market access teamsIndirect comparisons for NICE, CADTH, IQWiG or an EU Joint Clinical Assessment dossier, built to the agency’s own methods guide and defensible at critique.
Pharmaceutical and biotechnology teamsComparative effectiveness against the standard of care in markets where the comparator differs by country, and the network has to be rebuilt for each.
Academic researchers and doctoral scholarsA network meta-analysis as a thesis chapter or a first-author paper, where an examiner will ask how transitivity was assessed.
Clinicians and specialty societiesA ranking of the options in a condition where the trials each used a different comparator, with the uncertainty reported rather than buried.
Medical affairs and publications teamsComparative effectiveness evidence for a congress or a journal, with the network geometry shown so readers can see where the evidence is limited.

Deliverables

Four Deliverables Included in Every Network Meta-Analysis

Each project assesses whether a valid comparison can be made before any model is run.

Feasibility assessment before analysis Whether the network connects, whether the populations are similar enough to be compared, and whether outcomes are defined consistently enough to pool — assessed and reported before the analysis is commissioned.

Example from a feasibility assessmentA disconnected network cannot be analysed as a single network. A connected network of incomparable populations can be analysed but should not be, and this case carries greater risk because it still produces an estimate.

Transitivity examined against the study characteristics Effect modifiers are identified and compared across the trials that form each comparison, including baseline severity, line of therapy, follow-up and dose. Any differences are reported.

Example from a transitivity assessmentThe transitivity assumption was considered to be met.Trials in the A-versus-placebo comparison enrolled treatment-naive patients; the B-versus-placebo trials were second-line. Transitivity is questionable for this loop and the indirect estimate is presented with that limitation rather than alongside the others.

Inconsistency tested wherever a loop closes Direct and indirect estimates compared for every closed loop, by node-splitting or an equivalent, with the result reported whichever way it falls.

Example from a consistency checkWhere direct and indirect evidence disagree, the disagreement is reported as a finding. Pooling them into a single network estimate and reporting only that would conceal the most informative result of the analysis.

Analysis code and data The analysis scripts, the network data and the model specification, so results can be reproduced, rerun for a clarification round, or extended when a new trial reports.

Example from a handoverHTA clarification questions often request a scenario analysis at two weeks’ notice, so the client team needs code it can rerun independently.

The samples shown are illustrative and anonymised. Hover over a sample to replay it.

Compliance and Standards

Network Meta-Analysis Methodological Standards

These are the published methods that HTA assessors apply. Any departure from them is justified in the report.

TSD 2, 3, 4, 18

NICE DSU technical support (synthesis methods)

The generalised linear modelling framework for pairwise and network meta-analysis, heterogeneity, inconsistency and population-adjusted indirect comparison. These are the methods UK reviewers apply and a widely accepted default in other settings.

ISPOR–AMCP–NPC good practice (indirect comparison)

The task force reports on interpreting indirect treatment comparisons and network meta-analysis, and the questionnaire assessors use to decide whether a comparison is credible enough to act on.

PRISMA 2020 (and the NMA extension)

The reporting standard for systematic reviews, with the network meta-analysis extension adding the network geometry, the assumptions tested and the ranking caveats a reviewer expects to see stated.

ISO9001:2015

Quality management (cert. H3CR9TCU20251212INDQM10N)

Our certified quality system governs how work is run, recorded and released.

Responsible Use of AI

Responsible Use of AI in Model Selection and Consistency Checking

In network meta-analysis, the main question about AI is whether the model, priors and consistency checks were chosen by a statistician who can justify them. Software will fit a network without indicating that its geometry cannot support the analysis.

How We Use AI ToolsAI tools help locate and extract outcome data from trial reports, draft code that a statistician reads line by line before it is run, and flag reported estimates whose intervals do not reconcile.
Where We Do Not Use AIWe do not use AI to choose the model, priors or estimator, to judge transitivity or to interpret inconsistency. AI is not used on analyses for HTA submissions, where assessors trace every judgement to a named statistician.
What Your AI Declaration Should IncludeYour declaration states the tool, the stage at which it was used and the human oversight applied. Journals, funders and the ICMJE January 2026 update now expect this, and an undeclared tool found later is treated as a research integrity matter.

Why We Do Not Publish AI Accuracy Figures

Accuracy figures for AI tools are usually reported by the companies that sell them.

Pubrica therefore does not quote a self-generated accuracy figure, because it would carry the same conflict of interest. Instead, we tell you which tool was used on your project, at which stage, and what a specialist changed afterwards.

Methodology

How Our Network Meta-Analysis Process Works

The process has four stages. The feasibility assessment is a deliverable in its own right and can be commissioned on its own.

Step one

Evidence review and network mapping

Trials identified from a systematic review, the network drawn, and its geometry described — which comparisons are direct, which are indirect, where the loops are.

Step two

Feasibility assessment

Population, comparator and outcome comparability assessed across the network, with effect modifiers identified and differences reported.

Step three

Statistical analysis

Fixed and random effects models fitted, heterogeneity and inconsistency examined, and sensitivity to the questionable assumptions tested.

Step four

Reporting and handover

Results are reported in the format the submission requires, with assumptions and limitations stated, and the code and data are delivered.

Our Experts

Our Network Meta-Analysis Experts

A named team of subject specialists stays with your project from scoping to delivery. Your project coordinator introduces each team member by name before work begins.

Mr. JohnM.Sc. in Statistics · statistician

Responsible for every decision that depends on the numbers. Confirms before analysis begins whether the data can answer the question, and hands over the code so the analysis can be re-run independently.

Responsible forAnalysis and certainty
Reviews againstGRADE, SWiM, ICH E9
ToolsR, Stata, SAS, RevMan
Subject expertA subject matter expert matched to your topic

Determines what the work can claim on the basis of the evidence. The subject expert is matched to your topic and tells you clearly when the evidence does not support the intended conclusion.

Responsible forQuestion, scope, interpretation
Reviews againstICMJE, COPE, PRISMA
FieldMatched to your topic
Dr. DivyaPhD in Life Science · second reviewer

Reviews the work independently of the first pass and reconciles the two, because most errors in this work are transcription errors rather than errors of reasoning. All disagreements are logged and adjudicated.

Responsible forIndependent second review
Reviews againstRoB 2, ROBINS-I, QUADAS-3, JBI
Adjudicated byA third reviewer
Dr. AntonyInformation specialist

Identifies the evidence on which the work is based and documents the search so that it can be reproduced. Writes the search strategy line by line for each platform and delivers it dated and reproducible.

Responsible forSearch and retrieval
Reviews againstPRISMA-S, PRESS
Second-checked byA second information specialist

Pricing

Network Meta-Analysis Packages

Pricing depends on the number of trials in the network, the number of outcomes and whether population adjustment is required.

Feasibility assessment

Feasibility assessment

Before committing to the analysis

Quoted per projectOn network size

Delivery Quoted by scope

  • ✓Network drawn and geometry described
  • ✓Connectivity established
  • ✓Population and outcome comparability assessed
  • ✓Effect modifiers identified
  • ✓A clear recommendation on whether to proceed

Where the network cannot support the analysis, this is the lowest-cost way to find out, and it allows you to adjust your submission plan before analysis begins.

Deliverables Request a quote
NMA

Network meta-analysis

Connected networks

Quoted per projectOn trials and outcomes

Delivery Quoted by scope

  • ✓Fixed and random effects models
  • ✓Heterogeneity examined
  • ✓Inconsistency tested at every loop
  • ✓Rankings with their caveats
  • ✓Sensitivity analyses on the weak assumptions
  • ✓Code and data handed over

Built in R as standard. WinBUGS or JAGS where an agency or a journal expects it.

Deliverables Request a quote
Adjusted

Population-adjusted comparison

Where there is no common comparator

Quoted per projectOn IPD availability and covariates

Delivery Quoted by scope

  • ✓MAIC or STC as the data allows
  • ✓Built to NICE DSU TSD 18
  • ✓Effective sample size reported after weighting
  • ✓The unanchored assumption stated explicitly
  • ✓Sensitivity to covariate selection tested

An unanchored comparison assumes that every prognostic variable and effect modifier has been accounted for. Assessors recognise how strong this assumption is, so the report states it explicitly.

Deliverables Request a quote

Send your trial list and the comparators you have been asked about and we will draw the network at no cost, so you can see whether it connects before commissioning anything.

Benefits

Benefits of a Pubrica Network Meta-Analysis

Network meta-analysis provides four main benefits for HTA, guideline and publication work.

01Comparisons where no head-to-head trial existsA network meta-analysis compares treatments that were never tested against each other, using the comparators the trials share. Where the evidence allows, it places your treatment within the full set of options rather than against placebo alone.
02Analyses prepared for HTA critiqueThe assessments an assessor looks for — transitivity against the effect modifiers, consistency at every closed loop, and the geometry plotted — are done and reported rather than assumed, which is where most indirect comparisons are challenged.
03Rankings reported with their uncertaintySUCRA and P-score are easy to produce and easy to over-read. Pubrica reports them with the interval around them and says plainly when two treatments cannot be separated, because a ranking presented as a league table is the commonest misreading of this method.
04Reproducible analysis filesThe R or Bayesian code is delivered with the manuscript, so additional sensitivity analyses requested by reviewers can be run without starting a new project.

Quality Assurance

Our Service Commitments and Limitations

Our commitments and their limits are set out in full below, so that you can review them before you commission any work.

Our revision commitment

Revision Support Within the Agreed Scope

We continue working within the agreed scope until the work meets the agreed requirements. We offer continued revision support rather than refunds.

01

Unlimited revisions within the agreed scope

There is no cap on revision rounds and no time limit within the agreed scope. If the work does not meet what we agreed to deliver, we revise it. Any widening of the scope is quoted separately, and we confirm which applies before work starts.

02

Corrections at our cost

If the work comes back because of something we ran or wrote, correcting it is free.

03

Delivery on the agreed date

We quote a delivery date we can meet. If a milestone is at risk, we tell you early.

04

Mutual NDA on request

Signed before you send anything, in both directions, at no cost, and we are happy to sign your NDA rather than ours.

05

Final decisions remain with you

We advise, give our view and tell you clearly when we disagree, but decisions about what is published in your name are always yours.

9.4/10

Average client rating

From 3,000 responses to Pubrica’s own post-delivery survey, sent to every client at handover, January 2024 to June 2026. This figure comes from our own records rather than a third-party rating.

Service limitations. We cannot guarantee an outcome that belongs to somebody else — an editor’s decision, a funder’s panel, a regulator’s assessment. What we guarantee, within the agreed scope, is the work: done to the standard named on this page, delivered when we said, and corrected at our cost if we got it wrong.

FAQs

Network Meta-Analysis FAQs

If your question is not answered here, please ask an expert. No quote is required.

A disconnected network cannot be analysed as a network meta-analysis. The options are an unanchored comparison with population adjustment, which carries a much stronger assumption, or accepting that the comparison cannot be made.

We will tell you which applies before quoting the analysis. A forced network produces an estimate that assessors are likely to discount.

You can, with caveats. Rankings are routinely over-interpreted: a treatment can rank first on very sparse evidence, and a rank is not an effect size or a confidence statement.

We report them alongside the effect estimates and their uncertainty, so a reader cannot take the rank without the precision behind it.

R as standard — netmeta for frequentist analysis, gemtc or multinma for Bayesian work. It is easier to reproduce, easier to hand over and easier for your own team to rerun.

WinBUGS or JAGS where an agency, a journal or your own SOP expects it. The choice is yours and we will say when it makes no difference to the answer.

Yes, and that is why the code and network data are handed over. Adding a trial to an existing network is a fraction of the cost of rebuilding it.

Where the analysis supports a live HTA submission, an update on a scheduled basis is often the cheaper arrangement.

Related Services

Related Research Services

Network meta-analysis depends on the systematic review that identifies the trials, and these related services support each stage.

Request a Free Evidence Network Diagram

We will show you whether the network connects and whether the populations are comparable before you commit a budget.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.